Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind trial of TT-173 for haemostasis at skin graft donor sites
2013-002784-25Phase 2Completed
- Sponsor
- Thrombotargets Europe
- Start
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Not applicable and wound bleeding comparing TT-173 with Placebo/control (2 arms). Primary endpoint: Hemostasis time at donor site. Started Aug 2013; status: completed.
02
Drugs
TT-173
03
Conditions
Not applicablewound bleeding
Beyond the preview
Go deeper on 2013-002784-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002784-25.